Product
Relugolix + Estradiol + Norethindrone Acetate
Aliases
MVT-601, MVT-601A, MYFEMBREE, relugolix, Relugolix (1 other aliases)
Name
Myfembree
FDA Approved
Yes
1 clinical trial
1 organization
3 drugs
4 indications
2 documents
Indication
Pregnancy RelatedIndication
Pregnancy ComplicationsIndication
PregnancyIndication
High-riskDrug
relugolixDrug
EstradiolClinical trial
MYFEMBREE®: A Retrospective Cohort Study Using an Administrative Healthcare Database to Assess Pregnancy Outcomes in Women Treated With Relugolix Combination TherapyStatus: Not yet recruiting, Estimated PCD: 2027-05-01
Document
DailyMed Label: MyfembreeOrganization
Sumitomo Pharma America, Inc.Document
DailyMed Label: Orgovyx